Menu
Currency
GWAS Study

A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology.

Akbari P, Vuckovic D, Stefanucci L et al.

37596262 PubMed ID
GWAS Study Type
29675 Participants
62 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AP
Akbari P
VD
Vuckovic D
SL
Stefanucci L
JT
Jiang T
KK
Kundu K
KR
Kreuzhuber R
BE
Bao EL
CJ
Collins JH
DK
Downes K
GL
Grassi L
GJ
Guerrero JA
KS
Kaptoge S
KJ
Knight JC
MS
Meacham S
SJ
Sambrook J
SD
Seyres D
SO
Stegle O
VJ
Verboon JM
WK
Walter K
WN
Watkins NA
DJ
Danesh J
RD
Roberts DJ
DA
Di Angelantonio E
SV
Sankaran VG
FM
Frontini M
BS
Burgess S
KT
Kuijpers T
PJ
Peters JE
BA
Butterworth AS
OW
Ouwehand WH
SN
Soranzo N
AW
Astle WJ
Chapter II

Abstract

Summary of the research findings

Blood cells contain functionally important intracellular structures, such as granules, critical to immunity and thrombosis. Quantitative variation in these structures has not been subjected previously to large-scale genetic analysis. We perform genome-wide association studies of 63 flow-cytometry derived cellular phenotypes-including cell-type specific measures of granularity, nucleic acid content and reactivity-in 41,515 participants in the INTERVAL study. We identify 2172 distinct variant-trait associations, including associations near genes coding for proteins in organelles implicated in inflammatory and thrombotic diseases. By integrating with epigenetic data we show that many intracellular structures are likely to be determined in immature precursor cells. By integrating with proteomic data we identify the transcription factor FOG2 as an early regulator of platelet formation and α-granularity. Finally, we show that colocalisation of our associations with disease risk signals can suggest aetiological cell-types-variants in IL2RA and ITGA4 respectively mirror the known effects of daclizumab in multiple sclerosis and vedolizumab in inflammatory bowel disease.

29,675 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

29675
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.